<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01056341</url>
  </required_header>
  <id_info>
    <org_study_id>V00400 SB 201 Study</org_study_id>
    <nct_id>NCT01056341</nct_id>
  </id_info>
  <brief_title>Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy</brief_title>
  <official_title>A Randomised, Controlled, Multidose, Multicentre, Adaptive Phase II/III Study in Infants With Proliferating Infantile Hemangiomas (IHs) Requiring Systemic Therapy to Compare 4 Regimens of Propranolol (1 or 3 mg/kg/Day for 3 or 6 Months) to Placebo (Double Blind).</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pierre Fabre Dermatology</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pierre Fabre Dermatology</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is an unsatisfied medical need for a first-line treatment of proliferating IHs with a
      good benefit/risk profile. Based on the recent findings of encouraging results obtained with
      propranolol in a series of infants with severe Infantile Hemangioma (IH), propranolol is
      expected to be of significant benefit in the management of the condition. The present study
      has been designed to confirm efficacy of propranolol in severe IH by demonstrating
      superiority over placebo and to document the safety profile of propranolol in this
      indication.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary objective The primary objective of this study is to identify the appropriate dose and
      duration of propranolol treatment and demonstrate its superiority over placebo based on the
      complete/nearly complete resolution of target IH at W24.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Interim Analysis : Complete/Nearly Complete Resolution of the Target Infantile Hemangioma at Week 24 Compared to Baseline Based on the Intra-patient Blinded Centralized Independent Qualitative Assessments of Week 24 Photographs.</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Primary Analysis : Complete/Nearly Complete Resolution of the Target Infantile Hemangioma at W24 Compared to Baseline Based on the Intra-patient Blinded Centralized Independent Qualitative Assessments of W24 Photographs.</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Success/Failure Based on the Investigator Qualitative Assessment of Complete Resolution at W48.</measure>
    <time_frame>6 months</time_frame>
    <description>Time to first sustained improvement based on centralized qualitative assessments of paired patient-visits</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">512</enrollment>
  <condition>Infantile Hemangioma</condition>
  <arm_group>
    <arm_group_label>Propranolol oral solution</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propranolol</intervention_name>
    <description>Propranolol (1 or 3 mg/kg/day for 3 or 6 months)</description>
    <arm_group_label>Propranolol oral solution</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Treatment with placebo for 6 months</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Proliferating IH (target hemangioma) requiring systemic therapy anywhere on the body
             except on the diaper area with largest diameter of at least 1.5 cm

        Exclusion Criteria:

        - The patient presents with one or more of the following medical conditions: Congenital
        hemangioma; Kasabach-Merritt syndrome; bronchial asthma; bronchospasm; hypoglycaemia (&lt; 40
        mg/dl or at risk); untreated phaeochromocytoma; hypotension (&lt; 50/30 mmHg); second or third
        degree heart block; cardiogenic shock; metabolic acidosis; bradycardia (&lt; 80 bpm); severe
        peripheral arterial circulatory disturbances; Raynaud's phenomenon; sick sinus syndrome;
        uncontrolled heart failure or Prinzmetal's angina; documented PHACES syndrome with central
        nervous system involvement

          -  The patient has previously been treated for IH, including any surgical and/or medical
             procedures (e.g. laser therapy)

          -  The patient is known to have a hypersensitivity to propranolol and/or any other
             beta-blockers

          -  One or more of the following types of IH are present:

               -  Life-threatening IH

               -  Function-threatening IH (e.g. those causing impairment of vision, respiratory
                  compromise caused by airway lesions, etc.)

               -  Ulcerated IH (whatever the localisation) with pain and lack of response to simple
                  wound care measures

          -  The patient was born prematurely and has not yet reached his/her term equivalent age
             (e.g. an infant born 2 months prematurely cannot be included before the age of 2
             months)

          -  LVEF (left ventricular systolic function) ≤40% and/or cardiomyopathy and/or hereditary
             arrhythmia disorder
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Days</minimum_age>
    <maximum_age>150 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christine Labreze, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hopital de Bordeaux</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California</name>
      <address>
        <city>Irvine</city>
        <state>California</state>
        <zip>92697-1385</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lucile Packard Children's Hospital</name>
      <address>
        <city>Redwood City</city>
        <state>California</state>
        <zip>94063-5334</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rady Children's Hospital</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92123</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Miami Children's Hospital</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33155</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Memorial Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60614</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardinal Glennon Children's Hospital</name>
      <address>
        <city>St.Louis</city>
        <state>Missouri</state>
        <zip>63104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>State University of NY</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oregon Health Sciences University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dell Children's Medical center</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78723</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seattle Children's Hospital</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eastern Clinical Research Unit - Box Hill Hospital</name>
      <address>
        <city>Box Hill</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Children's Hospital</name>
      <address>
        <city>Melbourne</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sydney Children's Hospital</name>
      <address>
        <city>Randwick</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU St.Justine</name>
      <address>
        <city>Montreal</city>
        <zip>H3T 1C5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Hospital for Sick Children</name>
      <address>
        <city>Toronto</city>
        <zip>M5G 1H4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children Dermatology</name>
      <address>
        <city>Brno</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinic of Dermatovenerology, University</name>
      <address>
        <city>Prague</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Pellegrin-Enfants</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Femme Mère Enfant</name>
      <address>
        <city>Lyon</city>
        <zip>69677</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Hôtel Dieu</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Archet 2</name>
      <address>
        <city>Nice</city>
        <zip>06202</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Armand Trousseau</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Necker Enfants malades</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Robert Debre - Consultation de Dermatologie</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Nord-CHU St Etienne</name>
      <address>
        <city>St-Etienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital des enfants</name>
      <address>
        <city>Toulouse</city>
        <zip>31100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Clocheville</name>
      <address>
        <city>Tours</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Freiburg</name>
      <address>
        <city>Freiburg</city>
        <zip>D-79106</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kinderkrankenhaus Wilhelmstift</name>
      <address>
        <city>Hamburg</city>
        <zip>D-22149</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Schleswig-Holstein</name>
      <address>
        <city>Kiel</city>
        <zip>24105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kinderchirurgische Klinik Ludwig-Maximilians-Universität</name>
      <address>
        <city>München</city>
        <zip>D-30337</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heim Pál Gyermekkórház,</name>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Bari</name>
      <address>
        <city>Bari</city>
        <zip>70124</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinica Dermatologica</name>
      <address>
        <city>Milano</city>
        <zip>20122</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vilnius University Children's Hospital</name>
      <address>
        <city>Vilnius</city>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Infantil de Mexico Federico Gomez</name>
      <address>
        <city>Mexico CIty</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Auckland Dermatology</name>
      <address>
        <city>Auckland</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Waikato Clinical Research 2008 Ltd.</name>
      <address>
        <city>Hamilton</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinica Internacional</name>
      <address>
        <city>Lima</city>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Nacional Edgardo Rebagliati Martins</name>
      <address>
        <city>Lima</city>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto Nacional de Salud del Niño</name>
      <address>
        <city>Lima</city>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinika Chirurgii i Urologii Dzieci i Mlodziezy Akademii Medycznej</name>
      <address>
        <city>Gdansk</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Children's Hospital</name>
      <address>
        <city>Krakow</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Pediatric Surgery and Oncology</name>
      <address>
        <city>Lodz</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinika Onkologii, Centrum Zdrowia Dziecka</name>
      <address>
        <city>Warszawa</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic Urgenta pentru Copii Grigore Alexandrescu</name>
      <address>
        <city>Bucharest</city>
        <zip>011743</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>I.O.M.C Alfred Rusescu</name>
      <address>
        <city>Bucharest</city>
        <zip>020395</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul de Copii Dr. Victor Gomoiu</name>
      <address>
        <city>Bucharest</city>
        <zip>022102</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic de Urgenta pentu Copii Sf. Maria</name>
      <address>
        <city>Iasi</city>
        <zip>700309</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul de Urgenta Copii, Louis Turcanu</name>
      <address>
        <city>Timisoara</city>
        <zip>300011</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical University - Filatov Pediatric Hospital</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Pediatric Academy</name>
      <address>
        <city>St-Peterburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Neonatal Intensive Care Department</name>
      <address>
        <city>St-Peterburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Servicio de Dermatologia del Hospital Infantil</name>
      <address>
        <city>A Coruna</city>
        <zip>15006</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Sant Pau de Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>08025</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Infantil Niño Jesús</name>
      <address>
        <city>Madrid</city>
        <zip>28009</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital La Paz</name>
      <address>
        <city>Madrid</city>
        <zip>28056</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen del Rocio</name>
      <address>
        <city>Sevilla</city>
        <zip>41013</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Valencia</name>
      <address>
        <city>Valencia</city>
        <zip>15006</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Canada</country>
    <country>Czech Republic</country>
    <country>France</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>Italy</country>
    <country>Lithuania</country>
    <country>Mexico</country>
    <country>New Zealand</country>
    <country>Peru</country>
    <country>Poland</country>
    <country>Romania</country>
    <country>Russian Federation</country>
    <country>Spain</country>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taïeb A. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008 Jun 12;358(24):2649-51. doi: 10.1056/NEJMc0708819.</citation>
    <PMID>18550886</PMID>
  </reference>
  <reference>
    <citation>Sans V, de la Roque ED, Berge J, Grenier N, Boralevi F, Mazereeuw-Hautier J, Lipsker D, Dupuis E, Ezzedine K, Vergnes P, Taïeb A, Léauté-Labrèze C. Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics. 2009 Sep;124(3):e423-31. doi: 10.1542/peds.2008-3458. Epub 2009 Aug 10.</citation>
    <PMID>19706583</PMID>
  </reference>
  <results_reference>
    <citation>Léauté-Labrèze C, Hoeger P, Mazereeuw-Hautier J, Guibaud L, Baselga E, Posiunas G, Phillips RJ, Caceres H, Lopez Gutierrez JC, Ballona R, Friedlander SF, Powell J, Perek D, Metz B, Barbarot S, Maruani A, Szalai ZZ, Krol A, Boccara O, Foelster-Holst R, Febrer Bosch MI, Su J, Buckova H, Torrelo A, Cambazard F, Grantzow R, Wargon O, Wyrzykowski D, Roessler J, Bernabeu-Wittel J, Valencia AM, Przewratil P, Glick S, Pope E, Birchall N, Benjamin L, Mancini AJ, Vabres P, Souteyrand P, Frieden IJ, Berul CI, Mehta CR, Prey S, Boralevi F, Morgan CC, Heritier S, Delarue A, Voisard JJ. A randomized, controlled trial of oral propranolol in infantile hemangioma. N Engl J Med. 2015 Feb 19;372(8):735-46. doi: 10.1056/NEJMoa1404710.</citation>
    <PMID>25693013</PMID>
  </results_reference>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 24, 2010</study_first_submitted>
  <study_first_submitted_qc>January 24, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 26, 2010</study_first_posted>
  <results_first_submitted>April 9, 2014</results_first_submitted>
  <results_first_submitted_qc>May 21, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 24, 2014</results_first_posted>
  <disposition_first_submitted>March 27, 2013</disposition_first_submitted>
  <disposition_first_submitted_qc>March 28, 2013</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">April 4, 2013</disposition_first_posted>
  <last_update_submitted>November 12, 2015</last_update_submitted>
  <last_update_submitted_qc>November 12, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 10, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Infantile Hemangioma</keyword>
  <keyword>Propranolol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemangioma</mesh_term>
    <mesh_term>Hemangioma, Capillary</mesh_term>
    <mesh_term>Port-Wine Stain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propranolol</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>512 patients were included in the study (informed Consent Form signed). Among these 510 patients, 460 were randomized and 52 were screen failure
At least one inclusion criterion not met in 26 cases
Parent's decision in 12 cases
Other reasons in 15 cases.
One patient was not included for two reasons (Parent's decision and other reason)</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Placebo</title>
          <description>Placebo: Treatment with placebo for 6 months</description>
        </group>
        <group group_id="P2">
          <title>Propranolol 1mg/kg/d 3 Months</title>
          <description>Propranolol oral solution 1mg/kg/day for 3 months, then placebo for 3 months</description>
        </group>
        <group group_id="P3">
          <title>Propranolol 1 mg/kg/d 6 Months</title>
          <description>Propranolol oral solution 1mg/kg/day for 6 months</description>
        </group>
        <group group_id="P4">
          <title>Propranolol 3 mg/kg/d 3 Months</title>
          <description>Propranolol oral solution 3mg/kg/day for 3 months, then placebo for 3 months</description>
        </group>
        <group group_id="P5">
          <title>Propranolol 3 mg/kg/d 6 Months</title>
          <description>Propranolol oral solution 3mg/kg/day for 6 months</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="55"/>
                <participants group_id="P2" count="99"/>
                <participants group_id="P3" count="103"/>
                <participants group_id="P4" count="101"/>
                <participants group_id="P5" count="102"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Interim Analysis</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="41"/>
                <participants group_id="P3" count="41"/>
                <participants group_id="P4" count="40"/>
                <participants group_id="P5" count="43"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
                <participants group_id="P2" count="63"/>
                <participants group_id="P3" count="88"/>
                <participants group_id="P4" count="65"/>
                <participants group_id="P5" count="88"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="36"/>
                <participants group_id="P2" count="36"/>
                <participants group_id="P3" count="15"/>
                <participants group_id="P4" count="36"/>
                <participants group_id="P5" count="14"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Treatment Intolerance</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="2"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lack of Efficacy</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
                <participants group_id="P2" count="30"/>
                <participants group_id="P3" count="7"/>
                <participants group_id="P4" count="25"/>
                <participants group_id="P5" count="9"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other reasons</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="9"/>
                <participants group_id="P5" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Among the 460 randomized patients, 4 were not treated: 2 because of parent(s)'/guardian's decision (1 in 1mg/kg/day 6 months arm,1 in 3 mg/kg/day 3 months arm), 2 because of absence of adequate treatment on site (1 in 1 mg/kg/day 3 months arm and 1 in 3mg/kg/day 6 months arm).</population>
      <group_list>
        <group group_id="B1">
          <title>Placebo</title>
          <description>Placebo: Treatment with placebo for 6 months</description>
        </group>
        <group group_id="B2">
          <title>Propranolol 1mg/kg/d 3 Months</title>
          <description>Propranolol oral solution 1mg/kg/day for 3 months, then placebo for 3 months</description>
        </group>
        <group group_id="B3">
          <title>Propranolol 1 mg/kg/d 6 Months</title>
          <description>Propranolol oral solution 1mg/kg/day for 6 months</description>
        </group>
        <group group_id="B4">
          <title>Propranolol 3 mg/kg/d 3 Months</title>
          <description>Propranolol oral solution 3mg/kg/day for 3 months, then placebo for 3 months</description>
        </group>
        <group group_id="B5">
          <title>Propranolol 3 mg/kg/d 6 Months</title>
          <description>Propranolol oral solution 3mg/kg/day for 6 months</description>
        </group>
        <group group_id="B6">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="55"/>
            <count group_id="B2" value="98"/>
            <count group_id="B3" value="102"/>
            <count group_id="B4" value="100"/>
            <count group_id="B5" value="101"/>
            <count group_id="B6" value="456"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>DAYS</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="103.91" spread="31.06"/>
                    <measurement group_id="B2" value="103.58" spread="33.07"/>
                    <measurement group_id="B3" value="102.65" spread="30.12"/>
                    <measurement group_id="B4" value="107.53" spread="30.14"/>
                    <measurement group_id="B5" value="101.63" spread="31.00"/>
                    <measurement group_id="B6" value="103.85" spread="31.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                    <measurement group_id="B2" value="68"/>
                    <measurement group_id="B3" value="70"/>
                    <measurement group_id="B4" value="79"/>
                    <measurement group_id="B5" value="70"/>
                    <measurement group_id="B6" value="325"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="32"/>
                    <measurement group_id="B4" value="21"/>
                    <measurement group_id="B5" value="31"/>
                    <measurement group_id="B6" value="131"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="13"/>
                    <measurement group_id="B4" value="11"/>
                    <measurement group_id="B5" value="10"/>
                    <measurement group_id="B6" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Spain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="14"/>
                    <measurement group_id="B4" value="17"/>
                    <measurement group_id="B5" value="14"/>
                    <measurement group_id="B6" value="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lithuania</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="5"/>
                    <measurement group_id="B6" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Russian Federation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Italy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>France</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="18"/>
                    <measurement group_id="B4" value="22"/>
                    <measurement group_id="B5" value="28"/>
                    <measurement group_id="B6" value="114"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Czech Republic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hungary</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="2"/>
                    <measurement group_id="B6" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mexico</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Canada</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="2"/>
                    <measurement group_id="B6" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Poland</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="8"/>
                    <measurement group_id="B5" value="4"/>
                    <measurement group_id="B6" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Romania</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="2"/>
                    <measurement group_id="B6" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Peru</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="9"/>
                    <measurement group_id="B4" value="8"/>
                    <measurement group_id="B5" value="12"/>
                    <measurement group_id="B6" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Australia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="14"/>
                    <measurement group_id="B4" value="5"/>
                    <measurement group_id="B5" value="7"/>
                    <measurement group_id="B6" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Germany</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="9"/>
                    <measurement group_id="B4" value="17"/>
                    <measurement group_id="B5" value="9"/>
                    <measurement group_id="B6" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>New Zealand</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="3"/>
                    <measurement group_id="B6" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Infantile hemangioma localization</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>FACE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                    <measurement group_id="B2" value="71"/>
                    <measurement group_id="B3" value="72"/>
                    <measurement group_id="B4" value="64"/>
                    <measurement group_id="B5" value="71"/>
                    <measurement group_id="B6" value="318"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NONE FACE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="30"/>
                    <measurement group_id="B4" value="36"/>
                    <measurement group_id="B5" value="30"/>
                    <measurement group_id="B6" value="138"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Interim Analysis : Complete/Nearly Complete Resolution of the Target Infantile Hemangioma at Week 24 Compared to Baseline Based on the Intra-patient Blinded Centralized Independent Qualitative Assessments of Week 24 Photographs.</title>
        <time_frame>6 months</time_frame>
        <population>Among the 190 first randomized patients who entered the stage 1 of the study, 2 patients were not treated because of parent'/legal guardian's decision: 1 in the 1mg/kg/day 6 months arm and 1 in the 3 mg/kg/day 3 months arm.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo: Treatment with placebo for 6 months</description>
          </group>
          <group group_id="O2">
            <title>Propranolol 1mg/kg/d 3 Months</title>
            <description>Propranolol oral solution 1mg/kg/day for 3 months, then placebo for 3 months</description>
          </group>
          <group group_id="O3">
            <title>Propranolol 1 mg/kg/d 6 Months</title>
            <description>Propranolol oral solution 1mg/kg/day for 6 months</description>
          </group>
          <group group_id="O4">
            <title>Propranolol 3 mg/kg/d 3 Months</title>
            <description>Propranolol oral solution 3mg/kg/day for 3 months, then placebo for 3 months</description>
          </group>
          <group group_id="O5">
            <title>Propranolol 3 mg/kg/d 6 Months</title>
            <description>Propranolol oral solution 3mg/kg/day for 6 months</description>
          </group>
        </group_list>
        <measure>
          <title>Interim Analysis : Complete/Nearly Complete Resolution of the Target Infantile Hemangioma at Week 24 Compared to Baseline Based on the Intra-patient Blinded Centralized Independent Qualitative Assessments of Week 24 Photographs.</title>
          <population>Among the 190 first randomized patients who entered the stage 1 of the study, 2 patients were not treated because of parent'/legal guardian's decision: 1 in the 1mg/kg/day 6 months arm and 1 in the 3 mg/kg/day 3 months arm.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="41"/>
                <count group_id="O3" value="40"/>
                <count group_id="O4" value="39"/>
                <count group_id="O5" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.0"/>
                    <measurement group_id="O2" value="9.8"/>
                    <measurement group_id="O3" value="37.5"/>
                    <measurement group_id="O4" value="7.7"/>
                    <measurement group_id="O5" value="62.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <groups_desc>The interim analysis was carried out after the first 188 patients have completed their W24 visit or been withdrawn prematurely from study therapy. For each propranolol arm, individual hypotheses H0,i: θi≤0</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt; 0.0001</p_value>
            <p_value_desc>P-value not adjusted for multiplicity. An Independent Committee conducted this analysis to determine the most efficacious of all arms with a good safety profile.
P-value linked to the 3 mg/kg/day 6 months selected arm .</p_value_desc>
            <method>One-sided Z-tests</method>
            <method_desc>One-sided Z-tests for proportions (contrasts tests on placebo) with pooled variance</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Primary Analysis : Complete/Nearly Complete Resolution of the Target Infantile Hemangioma at W24 Compared to Baseline Based on the Intra-patient Blinded Centralized Independent Qualitative Assessments of W24 Photographs.</title>
        <time_frame>6 months</time_frame>
        <population>After the interim analysis results, the Independent Committee recommendations was to continue the trial with the 3 mg/kg/day6 months arm and the placebo arm. 55 randomized and treated patients in the placebo arm and 102 randomized patients in the 3 mg/kg/day6 months arm,1 was not treated because no unit of the assigned treatment available on site.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo: Treatment with placebo for 6 months</description>
          </group>
          <group group_id="O2">
            <title>Propranolol 3mg/kg/d 6 Months</title>
            <description>Propranolol 3 mg/kg/day for 6 months</description>
          </group>
        </group_list>
        <measure>
          <title>Primary Analysis : Complete/Nearly Complete Resolution of the Target Infantile Hemangioma at W24 Compared to Baseline Based on the Intra-patient Blinded Centralized Independent Qualitative Assessments of W24 Photographs.</title>
          <population>After the interim analysis results, the Independent Committee recommendations was to continue the trial with the 3 mg/kg/day6 months arm and the placebo arm. 55 randomized and treated patients in the placebo arm and 102 randomized patients in the 3 mg/kg/day6 months arm,1 was not treated because no unit of the assigned treatment available on site.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="55"/>
                <count group_id="O2" value="101"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.6"/>
                    <measurement group_id="O2" value="60.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The objective is to test the superiority of the selected arm using the approach of Posch et al.
The primary analysis was performed on the intent-to-treat population: all treated patients in Stage 1 and all treated patients in stage 2 randomized to placebo or the selected arm.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt; 0.0001</p_value>
            <p_value_desc>The methodology used guaranteed that the familywise type I error rate was below the nominal one-sided significance level of 0.005.</p_value_desc>
            <method>combination tests</method>
            <method_desc>Superiority was tested using the closed testing procedure and combination tests for all intersection hypotheses using Simes’ adjustment.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Success/Failure Based on the Investigator Qualitative Assessment of Complete Resolution at W48.</title>
        <description>Time to first sustained improvement based on centralized qualitative assessments of paired patient-visits</description>
        <time_frame>6 months</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Safety evaluation of the four regimens of oral propranolol (versus placebo) over a 24-week treatment period. Safety evaluation of the four previous regimens of oral propranolol (versus placebo) over a follow up period of 72 weeks (up to 96 weeks).</time_frame>
      <desc>Safety population included all participants who received at least one dose of Propranolol (1 or 3mg/kg/day for 3 or 6 months) or placebo.
Among the 456 treated patients, 65 were withdrawn during treatment period:22 in placebo arm, 13 in 1mg/kg/day 3months arm, 11 in 1mg/kg/day 6months arm, 13 in 3mg/kg/day 3months arm, 6 in 3mg/kg/day 6months arm.</desc>
      <group_list>
        <group group_id="E1">
          <title>W24-treatment Period-safety Set-Placebo</title>
          <description>Placebo: Treatment with placebo for 6 months</description>
        </group>
        <group group_id="E2">
          <title>W24-treatment Period-safety Set-Propranolol 1mg/kg/d 3 Months</title>
          <description>Propranolol hydrochloride oral solution 1mg/kg/day for 3 months, then placebo for 3 months</description>
        </group>
        <group group_id="E3">
          <title>W24-treatment Period-safety Set-Propranolol 1 mg/kg/d 6 Months</title>
          <description>Propranolol hydrochloride oral solution 1mg/kg/day for 6 months</description>
        </group>
        <group group_id="E4">
          <title>W24-treatment Period-safety Set-Propranolol 3 mg/kg/d 3 Months</title>
          <description>Propranolol hydrochloride oral solution 3mg/kg/day for 3 months, then placebo for 3 months</description>
        </group>
        <group group_id="E5">
          <title>W24-treatment Period-safety Set-Propranolol 3 mg/kg/d 6 Months</title>
          <description>Propranolol hydrochloride oral solution 3mg/kg/day for 6 months</description>
        </group>
        <group group_id="E6">
          <title>W72-follow-up Period of ex Placebo Group-safety Set</title>
          <description>72-week follow-up period without study treatment administration</description>
        </group>
        <group group_id="E7">
          <title>W72-follow-up Period of ex 1mg/kg/d 3 Months Group-safety Set</title>
          <description>72-week follow-up period without study treatment administration</description>
        </group>
        <group group_id="E8">
          <title>W72-follow-up Period of ex 1mg/kg/d 6 Months Group-safety Set</title>
          <description>72-week follow-up period without study treatment administration</description>
        </group>
        <group group_id="E9">
          <title>W72-follow-up Period of ex 3mg/kg/d 3 Months Group-safety Set</title>
          <description>72-week follow-up period without study treatment administration</description>
        </group>
        <group group_id="E10">
          <title>W72-follow-up Period of ex 3mg/kg/d 6 Months Group-safety Set</title>
          <description>72-week follow-up period without study treatment administration</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="5" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="6" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="5" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="5" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="7" subjects_at_risk="95"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Atrioventricular block second degree</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>Cyanosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>hip dysplasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Enterocolitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Condition aggravated</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>Drug ineffective</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>inflammation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>hyperthermia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Bronchiolitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>Bronchopneumonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>Rotavirus infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>Viraemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>respiratory tract infection viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>ear infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>gastroenteritis rotavirus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>otitis media acute</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>respiratory syncytial virus infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>tonsillitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="95"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Traumatic brain injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>dehydration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>ketoacidosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>type 1 diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Epilepsy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>convulsion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>febrile convulsion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Apathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>asphyxia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>asthma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>cough</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Ileostomy closure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>Inguinal hernia repair</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>cataract operation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>surgery</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>Finger amputation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>hip surgery</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>hospitalisation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>scrotal operation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="40" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="88" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="92" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="92" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="96" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="27" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="66" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="70" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="65" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="75" subjects_at_risk="95"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Conjunctivitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="8" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="7" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="8" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="7" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="9" subjects_at_risk="95"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>Diarrhea</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="17" subjects_at_risk="100"/>
                <counts group_id="E5" events="51" subjects_affected="28" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="10" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="9" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>Teething</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="23" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="16" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="22" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="5" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="9" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="7" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="8" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>Toothhache</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="10" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="4" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="10" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="13" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="4" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>gingival pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Irritability</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="24" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="22" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="28" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="6" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="21" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="15" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="20" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="24" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>condition aggravated</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="3" subjects_at_risk="95"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Bronchiolitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="9" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="6" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="9" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="11" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="10" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="16" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="12" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="14" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="18" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="20" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>Ear infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="6" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="13" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="13" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="14" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="17" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="11" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="7" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="9" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="14" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="14" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="29" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="21" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="32" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="34" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="8" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="26" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="20" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="24" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="30" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>Rhinitis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="9" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="7" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="6" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="20" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="16" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="5" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="7" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="15" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="13" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="11" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>tonsillitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="7" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="6" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="7" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="10" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>pharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="5" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="6" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="8" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>otite media</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="6" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="5" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="4" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="5" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>influenza</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="5" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>varicella</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="5" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="6" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="4" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>roseola</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="5" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="4" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>hand-foot-and-mouth disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="3" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="3" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>acute tonsillitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>croup infectious</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>eye infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>gastroenteritis viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Vaccination complication</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="8" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="95"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>decreased appetite</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="95"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Somnolence</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>hypotonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>Middle insomnia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>Sleep disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="7" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>agitation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="18" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="16" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="14" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="8" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="5" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="7" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="7" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>Rhinorrhea</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="3" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="5" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>nasal congestion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>asthma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="5" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="5" subjects_at_risk="95"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Dermatitis diaper</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="9" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="3" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="3" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>Eczema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="4" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="4" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>dermatitis atopic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="95"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Peripheral coldness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="102"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="100"/>
                <counts group_id="E5" subjects_affected="10" subjects_at_risk="101"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="91"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="95"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The investigators can reserve the right to publish or present study data; provided that the sponsor reviews the abstract or manuscript at least 60 days prior to the expected date of submission to the intended publisher or planned presentation.
Publication of study results by each site shall be made only after completion and finalisation of the study by all sites and first publication by the Sponsor.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Jean-Jacques VOISARD - General Manager -</name_or_title>
      <organization>Pierre Fabre Dermatologie</organization>
      <phone>+33 5 63 58 88 00</phone>
      <email>jean.jacques.voisard@pierre-fabre.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

